The Delhi High Court on Tuesday asked the Centre to prioritise treatment of the younger population and frame a policy on the distribution ...
The Delhi High Court on Tuesday asked the Centre to prioritise treatment of the younger population and frame a policy on the distribution of Liposomal Amphotericin B, an anti-fungal drug used to treat mucormycosis or “black fungus”, reported ANI.
Mucormycosis is a fungal infection that has been reported among hundreds of recovered Covid-19 patients. It is caused by a fungus named mucor, which is found on wet surfaces. The symptoms of the infection include headache, fever, pain under the eyes, nasal or sinus congestion, and partial loss of vision, among others.
“If we have to choose, the young will have to be chosen,” the court said. “They are the future. Eighty year olds are not going to carry this country forward. They have lived their lives.”
The court also clarified its statement, saying that it was not “discounting the emotional support” that the elderly generation provides to families that are closely bonded. But added that difficult choices had to be made amid the pandemic.
A division bench of Justices Vipin Sanghi and Jasmeet Singh asked the Centre to file a status report on the policies related to mucormycosis. The court will take up the matter on Friday.
The High Court asked the Centre to take a policy decision on manner in which...
